公司概覽
業務類別 Biotechnology
業務概覽 Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
公司地址 Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7
電話號碼 +353 16347800
傳真號碼 +353 16347850
公司網頁 https://www.jazzpharmaceuticals.com
員工數量 2890
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Renee D. Gala President, Chief Executive Officer and Director 美元 1.00M 08/06/2026
Dr. Robert Iannone, M.D. Executive Vice President, Global Head of Research and Development and Chief Medical Officer 美元 793.08K 08/06/2026
Mr. Philip L. Johnson Executive Vice President and Chief Financial Officer 美元 741.35K 08/06/2026
Ms. Neena M. Patil Executive Vice President and Chief Legal Officer 美元 715.48K 08/06/2026
Ms. Patricia Carr Senior Vice President and Chief Accounting Officer -- 08/06/2026
Ms. Samantha Pearce Executive Vice President and Chief Commercial Officer 美元 695.67K 09/10/2026
Ms. Mary Elizabeth Henderson Senior Vice President, Technical Operations -- 08/06/2026
 
董事會成員
董事會 職務 更新日期
Mr. Bruce C. Cozadd Chairperson of the Board 08/06/2026
Mr. Patrick G. Enright, M.B.A. Independent Director 08/06/2026
Dr. Norbert G. Riedel,PhD Independent Director 08/06/2026
Dr. Ted W. Love, M.D. Independent Director 08/06/2026
Mr. Rick E. Winningham Lead Independent Director 08/06/2026
Ms. Heather Ann McSharry Independent Director 08/06/2026
Mr. Patrick Thomas Kennedy Independent Director 08/06/2026
Mr. Seamus C. Mulligan Independent Director 08/06/2026
Ms. Renee D. Gala President, Chief Executive Officer and Director 08/06/2026
Ms. Laura J. Hamill Independent Director 08/06/2026
Ms. Jennifer E. Cook Independent Director 08/06/2026
Dr. Mark D. Smith, M.D. Independent Director 08/06/2026
 
所屬ETF (更新日期: 14/11/2026 03:34)
代號 名稱 佔比% ▼ 持有日期
ONEQFidelity Nasdaq Composite ETF0.02%30/10/2026
FFOGFranklin Focused Dynamic Growth ETF0.02%31/10/2026
ESGVVanguard ESG US Stock ETF0.02%30/09/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.02%30/10/2026
XTiShares Future Exponential Techs ETF0.02%30/10/2026
EZMWisdomTree U.S. MidCap Earnings ETF0.02%30/10/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%30/10/2026
VFMFVanguard US Multifactor ETF0.02%30/09/2026
IQSMNYLIM Candriam U.S. Mid Cap Equity ETF0.02%30/10/2026
VONEVanguard Russell 1000 ETF0.02%30/09/2026
BKMCBNY Mellon US Mid Cap Core Equity ETF0.02%31/10/2026
RWKInvesco S&P MidCap 400 Revenue ETF0.02%30/10/2026
BULPacer US Cash Cows Growth ETF0.01%30/10/2026
FADFirst Trust Multi Cap Gr AlphaDEX® ETF0.01%29/10/2026
LSVDLSV Disciplined Value ETF0.01%30/10/2026
FLQLFranklin US Large Cap Mltfctr Idx ETF0.01%31/10/2026
XJHiShares ESG Select Scrn S&P Mid-Cap ETF0.01%30/10/2026
DSIiShares ESG MSCI KLD 400 ETF0.01%30/10/2026
QVMMInvesco S&P MidCap 400 QVM Mlt-fctr ETF0.01%30/10/2026
VIDIVident International Equity Strategy ETF0.01%30/10/2026
  1    2    3    4   5    6    7    8    9    10    11  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.